title: Calls to suspend European sales of erlotinib for lung cancer.
authors: Sanjay
authors: S
authors: Tanday
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D004335:Drug and Narcotic Control; D016568:Drugs, Generic / Q000009:adverse effects / Q000627:therapeutic use*; D000069347:Erlotinib Hydrochloride / Q000009:adverse effects / Q000627:therapeutic use*; D005060:Europe; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D013810:Therapeutic Equivalency
chemical_list: D000970:Antineoplastic Agents; D016568:Drugs, Generic; D000069347:Erlotinib Hydrochloride